233 related articles for article (PubMed ID: 25721671)
1. 1α,25 dihydroxi-vitamin D₃ modulates CDK4 and CDK6 expression and localization.
Irazoqui AP; Heim NB; Boland RL; Buitrago CG
Biochem Biophys Res Commun; 2015 Mar; 459(1):137-42. PubMed ID: 25721671
[TBL] [Abstract][Full Text] [Related]
2. Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells.
Irazoqui AP; Boland RL; Buitrago CG
J Mol Endocrinol; 2014 Dec; 53(3):331-43. PubMed ID: 25316911
[TBL] [Abstract][Full Text] [Related]
3. Role of VDR in 1α,25-dihydroxyvitamin D3-dependent non-genomic activation of MAPKs, Src and Akt in skeletal muscle cells.
Buitrago C; Pardo VG; Boland R
J Steroid Biochem Mol Biol; 2013 Jul; 136():125-30. PubMed ID: 23470620
[TBL] [Abstract][Full Text] [Related]
4. 1α,25(OH)2D3-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells.
Buitrago CG; Arango NS; Boland RL
J Cell Biochem; 2012 Apr; 113(4):1170-81. PubMed ID: 22095470
[TBL] [Abstract][Full Text] [Related]
5. Caveolae and caveolin-1 are implicated in 1alpha,25(OH)2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells.
Buitrago C; Boland R
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):169-75. PubMed ID: 20211253
[TBL] [Abstract][Full Text] [Related]
6. Activation of MAPKs by 1alpha,25(OH)2-Vitamin D3 and 17beta-estradiol in skeletal muscle cells leads to phosphorylation of Elk-1 and CREB transcription factors.
Ronda AC; Buitrago C; Colicheo A; de Boland AR; Roldán E; Boland R
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):462-6. PubMed ID: 17197172
[TBL] [Abstract][Full Text] [Related]
7. MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2-vitamin D3 in the C2C12 muscle cell line.
Buitrago CG; Ronda AC; de Boland AR; Boland R
J Cell Biochem; 2006 Mar; 97(4):698-708. PubMed ID: 16215981
[TBL] [Abstract][Full Text] [Related]
8. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcitriol on the cell cycle of rhabdomyosarcoma cells.
Irazoqui AP; Gonzalez A; Buitrago C
J Steroid Biochem Mol Biol; 2022 Sep; 222():106146. PubMed ID: 35710090
[TBL] [Abstract][Full Text] [Related]
10. Involvement of ERK1/2, p38 MAPK, and PI3K/Akt signaling pathways in the regulation of cell cycle progression by PTHrP in colon adenocarcinoma cells.
Calvo N; Martín MJ; de Boland AR; Gentili C
Biochem Cell Biol; 2014 Aug; 92(4):305-15. PubMed ID: 25051885
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.
Wu W; Zhang X; Zanello LP
Cancer Lett; 2007 Aug; 254(1):75-86. PubMed ID: 17412493
[TBL] [Abstract][Full Text] [Related]
12. 1α,25-Dihydroxyvitamin D₃ inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer.
Pilon C; Urbanet R; Williams TA; Maekawa T; Vettore S; Sirianni R; Pezzi V; Mulatero P; Fassina A; Sasano H; Fallo F
J Steroid Biochem Mol Biol; 2014 Mar; 140():26-33. PubMed ID: 24269839
[TBL] [Abstract][Full Text] [Related]
13. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro.
Huhtakangas JA; Olivera CJ; Bishop JE; Zanello LP; Norman AW
Mol Endocrinol; 2004 Nov; 18(11):2660-71. PubMed ID: 15272054
[TBL] [Abstract][Full Text] [Related]
14. The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3).
Buitrago C; Vazquez G; De Boland AR; Boland R
Biochem Biophys Res Commun; 2001 Dec; 289(5):1150-6. PubMed ID: 11741312
[TBL] [Abstract][Full Text] [Related]
15. 1alpha,25(OH)(2)-Vitamin D(3) stimulates intestinal cell p38 MAPK activity and increases c-Fos expression.
Pardo VG; Boland R; de Boland AR
Int J Biochem Cell Biol; 2006; 38(7):1181-90. PubMed ID: 16483831
[TBL] [Abstract][Full Text] [Related]
16. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection.
Gaschott T; Stein J
Recent Results Cancer Res; 2003; 164():247-57. PubMed ID: 12899527
[TBL] [Abstract][Full Text] [Related]
17. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.
Garay E; Donnelly R; Wang X; Studzinski GP
J Cell Physiol; 2007 Dec; 213(3):816-25. PubMed ID: 17520689
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
19. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
20. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
